Phase 3 Readout~month

Phase 3 Topline: A Long-term Follow-up Study for Patients Treated With Galapagos CAR T-cell Therapies

Indication
Hematological Malignancies

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: A Long-term Follow-up Study for Patients Treated With Galapagos CAR T-cell Therapies — GLPG Phase 3 Readout | BioSniper